The Canada Research Continuity Emergency Fund (CRCEF) was announced on May 15, 2020, as part of the Government of Canada’s COVID-19 Economic Response Plan. The temporary program has been established to help sustain the research enterprise at Canadian universities and health research institutions that have been affected by the COVID-19 pandemic.
The program includes four funding stages. Three of the stages (Stages 1, 2 and 4) exclusively provide wage support for eligible research-related personnel. The remaining stage (Stage 3) supports COVID-19 related incurred costs associated with maintenance and ramp-up of research activities. For more information about the Program visit the CRCEF program webpage.
In order to ensure that applications received are representative of UNBC’s diverse research community, the Office of Research invites and encourages people from underrepresented groups (Indigenous, visible minorities, diversely-abled, women, LGBTQ2S+) to submit a Letter of Intent. We recognize the additional burden placed on everyone during the COVID-19 pandemic, but especially, and often disproportionately, on people from the four designated + groups.
Researchers who have eligible Stage 3 costs and would like to apply for these funds should submit a Letter of Intent to firstname.lastname@example.org outlining;
- Amount of actual eligible costs incurred that will be requested; and,
- Number of research projects for which eligible incurred costs are claimed at Stage 3, broken down by category (research maintenance, ramp-up).
Eligible expenses include:
- animal and specimen care through the crisis period;
- maintenance of equipment, software, cohorts, datasets, including warranties, licenses and service contracts;
- technological equipment for remote access to maintain assets;
- safety equipment for personnel dedicated to maintenance;
- re-organizing the research environment and activities;
- additional costs to bring the research back to its pre-pandemic level, including experiments or related to the restart of collections and datasets (e.g., population-based, environmental);
- user fees charged by shared platforms to researchers to restart research activities (e.g., animal- care facilities, digital labs);
- re-scheduling and restarting human and clinical trials;
- exceptional costs to access special facilities, shared platforms and resources, knowledge transfer meetings and workshops;
- restarting, reassembling and safety checks of equipment and facilities;
- reacquiring lost and donated laboratory and field supplies and equipment, reagents, perishable materials, laboratory animal and other living specimens; and
- personal protective equipment and related items for research-related personnel.
Refer to the eligible expenses page for more information.